Welcome to our dedicated page for Maximus SEC filings (Ticker: MMS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Maximus, Inc. filings document the regulatory record of a public government-services contractor with common stock listed under MMS. Its 8-K reports cover quarterly and annual operating results, financial condition, earnings guidance, capital-return actions, stock repurchase authorizations and senior officer changes.
The company’s proxy materials describe board elections, auditor ratification, advisory executive-compensation votes, equity compensation disclosures and shareholder voting results. Together, the filings address Maximus’s governance structure, executive compensation, common-stock capital actions and formal disclosures related to its U.S. Federal Services, U.S. Services and Outside the U.S. operating segments.
Maximus, Inc. reported slightly lower revenue but stronger profitability for the quarter ended March 31, 2026. Quarterly revenue was $1.31 billion, down from $1.36 billion a year ago, while net income edged up to $98.1 million and diluted EPS rose to $1.80 from $1.69.
For the first six months, revenue declined 4.1% to $2.65 billion, but net income increased to $192.0 million from $137.8 million as gross margin improved to 24.9% and operating margin to 11.1%. Adjusted EBITDA for the six months reached $358.4 million, reflecting lower cost of revenue, divestiture gains, and a capitalized software impairment charge of $6.9 million.
The U.S. Federal Services segment expanded operating margin to 17.0% despite modest revenue declines, while U.S. Services and Outside the U.S. saw revenue and margin pressure, with the international segment posting an operating loss. Operating cash flow was negative $54.9 million, driven partly by delayed collections on a large U.S. federal contract, and days sales outstanding increased. Maximus repurchased about 1.8 million shares for $142.0 million, ended with a Consolidated Net Total Leverage Ratio of 1.75x, and the board declared a quarterly dividend of $0.33 per share.
Maximus reported fiscal Q2 2026 results and raised full-year earnings guidance while authorizing a large new share repurchase program. Revenue was $1.31 billion versus $1.36 billion a year earlier, but profitability improved, with diluted EPS of $1.80 and adjusted diluted EPS of $2.07 compared to $1.69 and $2.01.
Adjusted EBITDA margin rose to 14.4%, supported by efficiency gains and AI-enabled automation. The company now expects full-year adjusted EBITDA margin of about 14.2% and adjusted EPS between $8.25 and $8.55, while keeping revenue guidance at $5.2–$5.35 billion and free cash flow at $450–$500 million.
The Board refreshed the share repurchase authorization up to $400 million after buying 2.0 million shares for roughly $151 million through May 1, 2026, and declared a quarterly dividend of $0.33 per share payable June 1, 2026.
Maximus Inc Schedule 13G shows Vanguard Capital Management beneficially owns 2,857,086 shares of Common Stock, representing 5.23% of the class. The filing states Vanguard has sole voting power over 419,450 shares and sole dispositive power over 2,857,086 shares. The Schedule 13G lists affiliated Vanguard entities in its explanatory comment and is signed on 04/30/2026.
Maximus Inc reported that Vanguard Portfolio Management beneficially owned 3,523,165 shares of Common Stock, representing 6.45% of the class as of 03/31/2026. The filing states Vanguard exercises sole dispositive power over those shares and discloses that ownership is held on behalf of multiple Vanguard-managed accounts and funds.
MAXIMUS, INC. reported initial insider holdings for General Counsel and Corporate Secretary Elizabeth Moellering. She directly holds 5,044.166 shares of common stock. Footnotes describe prior equity awards of restricted stock units that vest over multiple years, each representing the right to receive one share of common stock.
Moellering was granted 1,232 RSUs on April 1, 2024, 1,361 RSUs on November 25, 2024, and 2,850 RSUs on November 24, 2025, each vesting ratably over four years on specified September 30 vesting dates. Dividend equivalent rights accrue on these RSUs when dividends are paid on the common stock.
The Vanguard Group filed an amended Schedule 13G/A reporting beneficial ownership in Maximus Inc. The amendment states Vanguard and its reporting entities hold 0 shares of Maximus common stock, representing 0% of the class. The filing explains an internal realignment and disaggregation of certain Vanguard subsidiaries for SEC reporting purposes.
MAXIMUS, INC. director Jan Madsen reported an open-market sale of 742 shares of Common Stock at $72.25 per share. The transaction took place on March 17, 2026 and was made under a Rule 10b5-1 trading plan adopted on September 14, 2024.
Following this sale, Madsen directly holds 20,794.822 shares of MAXIMUS Common Stock. A 10b5-1 trading plan means the sale was pre-scheduled in advance, which typically indicates a routine approach to liquidity rather than a discretionary trade based on recent company developments.
Madsen Jan reported acquisition or exercise transactions in this Form 4 filing.
MAXIMUS, INC. director Jan Madsen received an equity grant of 3,215 shares of Common Stock in the form of restricted stock units on March 10, 2026. These RSUs vest one year from the grant date, reflecting routine director compensation rather than an open-market purchase.
Madsen elected to defer receipt of the underlying common stock until service on the board ends. Following this grant, direct holdings reported in Common Stock total 21,536.822 shares, which include 65.219 dividend-equivalent rights accrued on previously awarded RSUs.
HALEY JOHN J reported acquisition or exercise transactions in this Form 4 filing.
MAXIMUS, INC. director John J. Haley received an equity grant of 7,009 restricted stock units, a form of stock-based compensation. These RSUs vest one year from the grant date, and he has elected to defer receiving the common shares until his service on the board ends.
Following this grant, he holds 47,115.951 shares of common stock directly. He also has indirect holdings of 71,132 shares through the John J. Haley Grantor Retained Annuity Trust Seven and 32,764 shares through the John J. Haley Grantor Retained Annuity Trust Eight. The position includes 135.462 dividend equivalent rights that vest alongside earlier RSU awards.